296 related articles for article (PubMed ID: 17515125)
41. [Early transformation from follicular lymphoma to Burkitt lymphoma].
Takahashi T; Hara T; Yoshikawa T; Shimomura Y; Tsurumi H; Yamada T; Tomita E; Moriwaki H
Rinsho Ketsueki; 2005 Sep; 46(9):1055-9. PubMed ID: 16440764
[TBL] [Abstract][Full Text] [Related]
42. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
43. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
44. Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab.
Windebank K; Walwyn T; Kirk R; Parry G; Hasan A; Bown N; Wilkins B
Pediatr Blood Cancer; 2009 Sep; 53(3):392-6. PubMed ID: 19459198
[TBL] [Abstract][Full Text] [Related]
45. Burkitt lymphoma with dual translocation of chromosome 14: a novel chromosomal abnormality of t(8;14),t(14;15).
Moon Y; Kim M; Park G
Ann Clin Lab Sci; 2008; 38(1):75-9. PubMed ID: 18316785
[TBL] [Abstract][Full Text] [Related]
46. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
[TBL] [Abstract][Full Text] [Related]
47. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
[TBL] [Abstract][Full Text] [Related]
48. [Successful treatment with drainage of hematoma and chemotherapy in a case of Burkitt leukemia presenting with subdural hematoma].
Kitano A; Yamamoto K; Nagao T; Yoshida M; Kurosu T; Arai A; Miki T; Murakami N; Miura O
Rinsho Ketsueki; 2005 Apr; 46(4):278-80. PubMed ID: 16444961
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
[TBL] [Abstract][Full Text] [Related]
50. Burkitt's lymphoma in a 45-year-old Nigerian woman.
Lawal OO; Ojo OS; Durosinmi MA
Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
[TBL] [Abstract][Full Text] [Related]
51. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
[TBL] [Abstract][Full Text] [Related]
52. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Mead GM; Barrans SL; Qian W; Walewski J; Radford JA; Wolf M; Clawson SM; Stenning SP; Yule CL; Jack AS; ;
Blood; 2008 Sep; 112(6):2248-60. PubMed ID: 18612102
[TBL] [Abstract][Full Text] [Related]
53. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
54. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Noy A; Lee JY; Cesarman E; Ambinder R; Baiocchi R; Reid E; Ratner L; Wagner-Johnston N; Kaplan L;
Blood; 2015 Jul; 126(2):160-6. PubMed ID: 25957391
[TBL] [Abstract][Full Text] [Related]
55. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
[TBL] [Abstract][Full Text] [Related]
56. Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) & (14;18) translocations.
Gladstone B; Kadam PR; Balsara BR; Pai SK; Gopal R; Nair CN; Parikh PM; Saikia T; Advani SH
Indian J Med Res; 1994 Jun; 99():264-6. PubMed ID: 8088887
[TBL] [Abstract][Full Text] [Related]
57. Adult Burkitt lymphoma: advances in diagnosis and treatment.
Aldoss IT; Weisenburger DD; Fu K; Chan WC; Vose JM; Bierman PJ; Bociek RG; Armitage JO
Oncology (Williston Park); 2008 Nov; 22(13):1508-17. PubMed ID: 19133605
[TBL] [Abstract][Full Text] [Related]
58. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Lacasce A; Howard O; Lib S; Fisher D; Weng A; Neuberg D; Shipp M
Leuk Lymphoma; 2004 Apr; 45(4):761-7. PubMed ID: 15160953
[TBL] [Abstract][Full Text] [Related]
59. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
[TBL] [Abstract][Full Text] [Related]
60. [Acute lymphoblastic leukemia (L3) with t(2;3)(p12;q27), t(14;18)(q32;q21), and t(8;22)(q24;q11)].
Fujii S; Miyata A; Takeuchi M; Yoshino T
Rinsho Ketsueki; 2005 Feb; 46(2):134-40. PubMed ID: 16447707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]